Cargando…
Antibody and Nanobody Radiolabeling with Copper-64: Solid vs. Liquid Target Approach
Antibody and nanobody-based copper-64 radiopharmaceuticals are increasingly being proposed as theranostic tools in multiple human diseases. While the production of copper-64 using solid targets has been established for many years, its use is limited due to the complexity of solid target systems, whi...
Autores principales: | Hrynchak, Ivanna, Cocioabă, Diana, Fonseca, Alexandra I., Leonte, Radu, do Carmo, Sérgio J. C., Cornoiu, Roxana, Falcão, Amílcar, Niculae, Dana, Abrunhosa, Antero J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304849/ https://www.ncbi.nlm.nih.gov/pubmed/37375223 http://dx.doi.org/10.3390/molecules28124670 |
Ejemplares similares
-
Nanobody-Based Theranostic Agents for HER2-Positive Breast Cancer: Radiolabeling Strategies
por: Hrynchak, Ivanna, et al.
Publicado: (2021) -
Modifications in cellular viability, DNA damage and stress responses inflicted in cancer cells by copper-64 ions
por: Serban, Radu M., et al.
Publicado: (2023) -
Production of GMP-Compliant Clinical Amounts of Copper-61 Radiopharmaceuticals from Liquid Targets
por: Fonseca, Alexandra I., et al.
Publicado: (2022) -
In Vivo Tracking of Extracellular Vesicles by Nuclear Imaging: Advances in Radiolabeling Strategies
por: Almeida, Sara, et al.
Publicado: (2020) -
Advances in the automated synthesis of 6-[(18)F]Fluoro-L-DOPA
por: Neves, Ângela C. B., et al.
Publicado: (2021)